Thu, 03 Jan 2019 14:25:22 GMT
Bristol-Myers to acquire Celgene for $74B
On Thursday, Bristol-Myers Squibb announced it would expand its portfolio with the acquisition of Celgene Corp worth about $74B, marking one of the largest merger deals in the cancer drug sector.